Efficacy of interferon-γ in patients with refractory bullous pemphigoid

Journal of Dermatology

Volumn 34, Issue 11, 2007, Pages 737-745

  Nakama, Takekuni ^a   Ishii, Norito ^a   Ono, Fumitake ^a   Hamada, Takahiro ^a   Yasumoto, Shinichiro ^a   Hashimoto, Takashi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

BP180 enzyme linked immunosorbent assay; Bullous pemphigoid; Eosinophil; Interferon (IFN) ; Th2 cytokine

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 5; MINOCYCLINE; NICOTINAMIDE; PREDNISOLONE; RANTES; TETRACYCLINE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BULLOUS PEMPHIGOID; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; HUMAN; IMMUNOFLUORESCENCE; INFUSION; MALE; PROTEIN BLOOD LEVEL; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AUTOANTIBODIES; AUTOANTIGENS; CYTOKINES; DRUG THERAPY, COMBINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLUCOCORTICOIDS; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON TYPE II; MALE; MIDDLE AGED; NON-FIBRILLAR COLLAGENS; PEMPHIGOID, BULLOUS; PREDNISOLONE; SKIN; TREATMENT OUTCOME;

EID: 35648990075     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2007.00375.x     Document Type: Article

References (29)

1. Jung M, Kippes W, Messer G et al. Increased risk of bullous pemphigoid in male and very old patients: a population-based study on incidence. J Am Acad Dermatol 1999 41 : 266 268.
2. Wojnarowska F, Kirtschig G, Highet AS, Venning VA, Khumalo NP. Guidelines for the management of bullous pemphigoid. Br J Dermatol 2002 147 : 214 221.
3. Kawahara Y, Hashimoto T, Ohata K, Nishikawa T. Eleven cases of bullous pemphigoid treated with combination of minocycline and nicotinamide. Eur J Dermatol 1996 6 : 427 429.
4. Kolbach DN, Remme JJ, Bos WH et al. Bullous pemphigoid successfully controlled by tetracycline and nicotinamide. Br J Dermatol 1995 133 : 88 90.
5. Church R. Pemphigoid treated with corticosteroids. Br J Dermatol 1960 72 : 434 441.
6. Downham TF, Chapel TA. Bullous pemphigoid. Arch Dermatol 1978 114 : 1639 1642.
7. Fivenson D, Breneman D, Rosen G, Hersh C, Cardon S, Mutasim D. Nicotinamide and tetracycline therapy of bullous pemphigoid. Arch Dermatol 1994 130 : 753 758.
8. Hornschuh B, Hamm H, Weber S et al. Treatment of 16 patients with bullous pemphigoid with oral tetracycline and nicotinamide and topical clobetasol. J Am Acad Dermatol 1997 36 : 101 103.
9. Nakama T, Tsuda S, Miyasato M, Nakano T, Sasai Y. Immunohistochemical evaluation of eosinophil using mouse anti-human ECP monoclonal antibody (EG2). J Clin Exp Med (IGAKU NO AYUMI) 1989 150 : 231 232.
10. Nakama T, Tsuda S. Ultrastructural and immunocytochemical aspects of infiltrated eosinophils in bullous pemphigoid. Electron Microscopy in Dermatology. Basic and Clinical Research edited by ISHIBASHI et al., Excerpta Medica 1994 : 181 185.
11. Wintroub BU, Dvorak AM, Mihm Jr. MC, Gleich GJ. Bullous pemphigoid: cytotoxic eosinophil degranulation and release of eosinophil major basic protein. J Invest Dermatol 1981 76 : 310 311.
12. Dvorak AM, Mihm Jr. MC, Osage JE, Kwan TH, Austen KF, Wintroub BU. Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient. J Invest Dermatol 1982 78 : 91 101.
13. Baba T, Sonozaki H, Seki K, Uchiyama M, Ikesawa Y, Torisu M. An eosinophilic chemotactic factor present in blister fluid of bullous pemphigoid. J Immunol 1976 116 : 112 116.
14. Czarnetzki BM, Kalveram KJ, Dierksmeier U. Serum eosinophil chemotactic factor levels in patients with bullous pemphigoid, drug reactions and atopic eczema. J Invest Dermatol 1979 73 : 163 165.
15. Miyasato M, Tsuda S, Kasada M, Iryo K, Sasai Y. Alteration in the density, morphology, and biological properties of eosinophils produced by bullous pemphigoid blister fluid. Arch Dermatol Res 1989 281 : 304 309.
16. Tsuda S, Miyasato M. Allergic dermatosis "Basic and Clinical Aspect". Kyowa Kikaku Tsushin Co., Ltd. Tokyo, 1989 : 59 68.
17. Tsuda S, Miyasato M, Iryo K, Nakama T, Kato K, Sasai Y. Eosinophil phenotypes in bullous pemphigoid. J Dermatol 1992 19 : 270 279.
18. De Pita O, Frezzolini A, Chianchini G, Ruffelli M, Teofoli P, Puddu P. T-helper 2 involvement in the pathogenesis of bullous pemphigoid: role of soluble CD30 (sCD30). Arch Dermatol 1997 289 : 667 670.
19. Budinger L, Borradori L, Yee C et al. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest 1998 102 : 2082 2089.
20. Rico MJ, Benning C, Weingart ES, Streilein RD, Hall RP. Characterization of skin cytokines in bullous pemphigoid and pemphigus vulgaris. Br J Dermatol 1999 140 : 1079 1086.
21. Frezzolini A, Teofoli P, Chianchini G et al. Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid. Eur J Dermatol 2002 12 : 27 31.
22. Stanley JR. Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid; bullous disease due to defective epidermal cell adhesion. Adv Immunol 1993 53 : 291 325.
23. Liu Z, Giudice GJ, Swartz SJ et al. The role of complement in experimental bullous pemphigoid. J Clin Invest 1995 95 : 1539 1544.
24. Liu Z, Giudice GJ, Zhou X, Swartz SJ et al. A major role for neutrophils in experimental bullous pemphigoid. J Clin Invest 1997 100 : 1256 1263.
25. Giudice GJ, Emery DJ, Zelickson BD, Anhalt GJ, Liu Z, Diaz LA. Bullous pemphigoid and herpes gestationic autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J Immunol 1993 151 : 5742 5750.
26. Matsumura K, Amagai M, Nishikawa T, Hashimoto T. The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180 KDa bullous pemphigoid antigen. Arch Dermatol Res 1996 288 : 507 509.
27. Zillikens D, Mascaro JM, Rose PA et al. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. J Invest Dermatol 1997 109 : 679 683.
28. Schmidt E, Obe K, Brocker EB, Zillikens D. Serum level of autoantibodies to BP180 correlate with disease activity in patients with bullous pemohigoid. Arch Dermatol 2000 136 : 174 178.
29. Amo Y, Ohkawa T, Tatsuta M et al. Clinical significance of enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. J Dermatol Sci 2001 26 : 14 18.